Admescope is a Finnish Contract Research Organisation, providing pre-clinical ADME-Tox research services for Biotech and Pharma companies around the world. Currently, our customers come from 29 countries from Asia, Europe and North America.
We are hiring a Senior ADME Scientist with a strong experience in and understanding of absorption, distribution, metabolism and excretion (ADME) of drugs and related toxicology.
The position comprises mainly of designing and directing the studies we perform for our customers, instructing and supporting laboratory technicians and scientist in their experiments, processing and interpreting the experimental data into results and reports, and communicating with our customers.
You have a university degree in a suitable field (e.g. pharmacy, pharmaceutical chemistry) and at least five years of experience and/or doctoral research in a field of ADME-tox. Experience in LC/MS analytics, animal work and in vivo studies are considered as a benefit.
We offer an interesting, versatile and challenging position in a strongly growing company with a great atmosphere, and possibility for collaboration with international Biotech and Pharma companies. The position is available at our site in Oulu, Finland and will be filled in fall 2020.
Please send your application with salary request along with your CV, highlighting the relevant education and work experience at the latest October 25th 2020. For further information please contact Executive Search Consultant Petri Heikkinen, tel +358 40 752 9776.
Admescope Ltd is a privately owned Finnish company founded in 2011. Straight from the beginning, Admescope’s growth has been exponential and today Admescope is managed by a team with a strong background in CRO business.
The team consists of chemists, biochemists, pharmacologists and technicians, all with long experience and strong expertise in ADME-studies. Admescope serves customers in 29 different countries on four continents, having planned and conducted a high number of ADME-related studies to biotech and big pharma companies. In addition to our HQ and primary research site in Oulu, Finland, we have a research site in Södertälje, Sweden.